The most accurate and sensitive screening test available and will be transformative in tackling prostate cancer in men who may have no idea if anything is wrong with them.
Geneva, February 17, 2025: Unilabs, a top diagnostic services provider in Europe, has partnered with Oxipit, a leading medical imaging AI company, to implement AI-powered chest X-ray solutions across its European network. Through this partnership, Unilabs will integrate Oxipit’s AI solutions, ChestLink and ChestEye, into its radiology workflows, enhancing
Latent Labs, a pioneering AI-driven biotech startup, has secured $50 million in funding to transform how proteins are designed. Latent Labs is at the forefront of an industry shift where scientists no longer just study biology, they program it.
The UK has firmly established itself as a global innovator. With remarkable progress in bioscience advancements and bio-pharma developments, the country continues to push the limits of what’s possible in modern healthcare.
Microfluidics is reshaping diagnostics, offering faster, more precise, and cost-effective solutions. However, the journey from breakthrough research to real-world applications comes with significant challenges. In a recent interview, Paul Marshall, CEO of Rapid Fluidics Ltd, talked with Muhammad Younis about the evolving landscape of microfluidics, the key advancements needed to